Literature DB >> 30830262

Macrophage alterations in islets of obese mice linked to beta cell disruption in diabetes.

Jeng Yie Chan1, Kailun Lee1, Emma L Maxwell1, Cassandra Liang1, D Ross Laybutt2.   

Abstract

AIMS/HYPOTHESIS: Mild islet inflammation has been suggested as a contributing factor to beta cell failure in type 2 diabetes. Macrophage levels are elevated in the islets of humans and mice with type 2 diabetes, but their effects on beta cells are not understood. Our goal was to examine the gene expression changes in islet-associated macrophages in obesity models with opposing disposition to diabetes development and to assess their potential contribution to beta cell (mal)adaptation.
METHODS: Islets were isolated from lean control mice, obese diabetes-prone db/db mice and obese diabetes-resistant ob/ob mice. Macrophages were sorted using flow cytometry. Islets were treated ex vivo with clodronate-containing liposomes to deplete macrophages. Gene expression was assessed by real-time RT-PCR.
RESULTS: Macrophage levels were increased in islets from db/db mice but not in islets from ob/ob mice compared with lean control mice. Macrophages from db/db and ob/ob islets displayed distinct changes in gene expression compared with control islet macrophages, suggesting differential shifts in functional state. Macrophages from db/db islets displayed increased expression of interferon regulatory factor 5 (Irf5), IL-1 receptor antagonist (Il1rn) and mannose receptor C-type 1 (Mrc1), whereas macrophages from ob/ob islets showed elevated levels of transforming growth factor beta 1 (Tgfb1) and reduced IL-1β (Il1b). Clodronate-liposome treatment of islets depleted macrophages, as evidenced by reduced mRNA expression of Cd11b (also known as Itgam) and F4/80 (also known as Adgre1) compared with PBS-liposome-treated islets. The depletion of macrophages in db/db islets increased the expression of genes related to beta cell identity. The mRNA levels of islet-associated transcription factors (Mafa and Pdx1), glucose transporter (Glut2 [also known as Slc2a2]), ATP-sensitive K+ channel (Kcnj11), incretin receptor (Gipr) and adaptive unfolded protein response (UPR) genes (Xbp1, Hspa5, Pdia4 and Fkbp11) were increased in db/db islets after macrophage depletion, whereas the mRNA levels of the deleterious UPR effector, Ddit3, were reduced. In contrast, depletion of macrophages in islets of ob/ob mice did not affect beta cell identity gene expression. CONCLUSIONS/
INTERPRETATION: The findings of this study suggest that distinct alterations in islet macrophages of obese mice are critically important for the disruption of beta cell gene expression in diabetes.

Entities:  

Keywords:  Beta cell; Gene expression; Inflammation; Islets; Macrophage; Type 2 diabetes; Unfolded protein response

Mesh:

Substances:

Year:  2019        PMID: 30830262     DOI: 10.1007/s00125-019-4844-y

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  10 in total

Review 1.  Inflammation in obesity and diabetes: islet dysfunction and therapeutic opportunity.

Authors:  Marc Y Donath; Élise Dalmas; Nadine S Sauter; Marianne Böni-Schnetzler
Journal:  Cell Metab       Date:  2013-06-04       Impact factor: 27.287

Review 2.  Islet inflammation in type 2 diabetes and physiology.

Authors:  Kosei Eguchi; Ryozo Nagai
Journal:  J Clin Invest       Date:  2017-01-03       Impact factor: 14.808

Review 3.  Mechanisms of β-cell dedifferentiation in diabetes: recent findings and future research directions.

Authors:  Mohammed Bensellam; Jean-Christophe Jonas; D Ross Laybutt
Journal:  J Endocrinol       Date:  2017-12-04       Impact factor: 4.286

4.  Dual and opposing roles of the unfolded protein response regulated by IRE1alpha and XBP1 in proinsulin processing and insulin secretion.

Authors:  Ann-Hwee Lee; Keely Heidtman; Gökhan S Hotamisligil; Laurie H Glimcher
Journal:  Proc Natl Acad Sci U S A       Date:  2011-05-09       Impact factor: 11.205

5.  Increased number of islet-associated macrophages in type 2 diabetes.

Authors:  Jan A Ehses; Aurel Perren; Elisabeth Eppler; Pascale Ribaux; John A Pospisilik; Ranit Maor-Cahn; Xavier Gueripel; Helga Ellingsgaard; Marten K J Schneider; Gregoire Biollaz; Adriano Fontana; Manfred Reinecke; Francoise Homo-Delarche; Marc Y Donath
Journal:  Diabetes       Date:  2007-06-19       Impact factor: 9.461

6.  Anti-Inflammatory Therapy With Canakinumab for the Prevention and Management of Diabetes.

Authors:  Brendan M Everett; Marc Y Donath; Aruna D Pradhan; Tom Thuren; Prem Pais; Jose C Nicolau; Robert J Glynn; Peter Libby; Paul M Ridker
Journal:  J Am Coll Cardiol       Date:  2018-03-12       Impact factor: 24.094

7.  Pancreatic β cell dedifferentiation as a mechanism of diabetic β cell failure.

Authors:  Chutima Talchai; Shouhong Xuan; Hua V Lin; Lori Sussel; Domenico Accili
Journal:  Cell       Date:  2012-09-14       Impact factor: 41.582

8.  Failure of the adaptive unfolded protein response in islets of obese mice is linked with abnormalities in β-cell gene expression and progression to diabetes.

Authors:  Jeng Yie Chan; Jude Luzuriaga; Mohammed Bensellam; Trevor J Biden; D Ross Laybutt
Journal:  Diabetes       Date:  2012-12-28       Impact factor: 9.461

9.  The islet-resident macrophage is in an inflammatory state and senses microbial products in blood.

Authors:  Stephen T Ferris; Pavel N Zakharov; Xiaoxiao Wan; Boris Calderon; Maxim N Artyomov; Emil R Unanue; Javier A Carrero
Journal:  J Exp Med       Date:  2017-06-19       Impact factor: 14.307

10.  Aberrant islet unfolded protein response in type 2 diabetes.

Authors:  Feyza Engin; Truc Nguyen; Alena Yermalovich; Gökhan S Hotamisligil
Journal:  Sci Rep       Date:  2014-02-11       Impact factor: 4.379

  10 in total
  11 in total

1.  Glyoxalase 1 knockdown induces age-related β-cell dysfunction and glucose intolerance in mice.

Authors:  Immacolata Prevenzano; Alessia Leone; Michele Longo; Antonella Nicolò; Serena Cabaro; Francesca Collina; Iacopo Panarese; Gerardo Botti; Pietro Formisano; Raffaele Napoli; Francesco Beguinot; Claudia Miele; Cecilia Nigro
Journal:  EMBO Rep       Date:  2022-05-27       Impact factor: 9.071

Review 2.  Islet Inflammation and β Cell Dysfunction in Type 2 Diabetes.

Authors:  Joyceline Cuenco; Elise Dalmas
Journal:  Handb Exp Pharmacol       Date:  2022

Review 3.  Good Cop, Bad Cop: The Opposing Effects of Macrophage Activation State on Maintaining or Damaging Functional β-Cell Mass.

Authors:  Daelin M Jensen; Kyle V Hendricks; Austin T Mason; Jeffery S Tessem
Journal:  Metabolites       Date:  2020-11-26

Review 4.  Emerging Roles of Metallothioneins in Beta Cell Pathophysiology: Beyond and Above Metal Homeostasis and Antioxidant Response.

Authors:  Mohammed Bensellam; D Ross Laybutt; Jean-Christophe Jonas
Journal:  Biology (Basel)       Date:  2021-02-26

Review 5.  Involvement of Interleukin-1 Receptor-Associated Kinase 4 and Interferon Regulatory Factor 5 in the Immunopathogenesis of SARS-CoV-2 Infection: Implications for the Treatment of COVID-19.

Authors:  Nicholas Stoy
Journal:  Front Immunol       Date:  2021-04-07       Impact factor: 7.561

6.  Chemical inducer of regucalcin attenuates lipopolysaccharide-induced inflammatory responses in pancreatic MIN6 β-cells and RAW264.7 macrophages.

Authors:  Tomiyasu Murata; Kazunori Hashimoto; Susumu Kohno; Chiaki Takahashi; Masayoshi Yamaguchi; Chihiro Ito; Itoigawa Masataka; Roji Kojima; Kiyomi Hikita; Norio Kaneda
Journal:  FEBS Open Bio       Date:  2021-11-09       Impact factor: 2.693

Review 7.  Cellular Senescence in Diabetes Mellitus: Distinct Senotherapeutic Strategies for Adipose Tissue and Pancreatic β Cells.

Authors:  Takaaki Murakami; Nobuya Inagaki; Hiroshi Kondoh
Journal:  Front Endocrinol (Lausanne)       Date:  2022-03-31       Impact factor: 6.055

8.  FK506-Binding Protein 11 Is a Novel Plasma Cell-Specific Antibody Folding Catalyst with Increased Expression in Idiopathic Pulmonary Fibrosis.

Authors:  Stefan Preisendörfer; Yoshihiro Ishikawa; Elisabeth Hennen; Stephan Winklmeier; Jonas C Schupp; Larissa Knüppel; Isis E Fernandez; Leonhard Binzenhöfer; Andrew Flatley; Brenda M Juan-Guardela; Clemens Ruppert; Andreas Guenther; Marion Frankenberger; Rudolf A Hatz; Nikolaus Kneidinger; Jürgen Behr; Regina Feederle; Aloys Schepers; Anne Hilgendorff; Naftali Kaminski; Edgar Meinl; Hans Peter Bächinger; Oliver Eickelberg; Claudia A Staab-Weijnitz
Journal:  Cells       Date:  2022-04-14       Impact factor: 7.666

Review 9.  Targeting innate immune mediators in type 1 and type 2 diabetes.

Authors:  Marc Y Donath; Charles A Dinarello; Thomas Mandrup-Poulsen
Journal:  Nat Rev Immunol       Date:  2019-09-09       Impact factor: 53.106

Review 10.  Role of Cellular Senescence in Type II Diabetes.

Authors:  Akilavalli Narasimhan; Rafael R Flores; Paul D Robbins; Laura J Niedernhofer
Journal:  Endocrinology       Date:  2021-10-01       Impact factor: 5.051

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.